
Sign up to save your podcasts
Or
Ovarian cancer is the deadliest gynecological cancer today. With the much-needed innovation in ovarian cancer research, it’s crucial women understand the complexity and potential for change in this disease.
For Ovarian Cancer Awareness Month, we spoke with Oriana Papin-Zoghbi, the CEO and Co-founder of AOA Dx. AOA Dx is a biotech company focused on early-stage ovarian cancer detection, actively spreading awareness and working toward solutions for women’s health issues.
In this episode, we discuss current insights into ovarian cancer research and prognosis. Oriana shares some ovarian cancer stories and what AOA Dx is doing to help women catch the disease early. We cover the average ovarian cancer survival rate, some symptoms of ovarian cancer, and ways to advocate for better testing in women’s health.
Discussed in this episode:
Related to this episode:
Resources and episodes on Female Cancer
1. Help others discover Fempower Health:
Leave a quick review on Apple or Spotify. It’s the easiest way to support our mission and amplify women’s health voices.
2. Stay connected:
Follow us on LinkedIn, Instagram and TikTok, YouTube for real-time updates, expert insights, and relatable conversations.
Or join our newsletter to get curated women's health content—on your terms, in your inbox.
**Top 50 Health Podcast of 2024**
**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor. Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**
**May contain affiliate links and I will be compensated if you make a purchase after clicking on my links**
4.7
4141 ratings
Ovarian cancer is the deadliest gynecological cancer today. With the much-needed innovation in ovarian cancer research, it’s crucial women understand the complexity and potential for change in this disease.
For Ovarian Cancer Awareness Month, we spoke with Oriana Papin-Zoghbi, the CEO and Co-founder of AOA Dx. AOA Dx is a biotech company focused on early-stage ovarian cancer detection, actively spreading awareness and working toward solutions for women’s health issues.
In this episode, we discuss current insights into ovarian cancer research and prognosis. Oriana shares some ovarian cancer stories and what AOA Dx is doing to help women catch the disease early. We cover the average ovarian cancer survival rate, some symptoms of ovarian cancer, and ways to advocate for better testing in women’s health.
Discussed in this episode:
Related to this episode:
Resources and episodes on Female Cancer
1. Help others discover Fempower Health:
Leave a quick review on Apple or Spotify. It’s the easiest way to support our mission and amplify women’s health voices.
2. Stay connected:
Follow us on LinkedIn, Instagram and TikTok, YouTube for real-time updates, expert insights, and relatable conversations.
Or join our newsletter to get curated women's health content—on your terms, in your inbox.
**Top 50 Health Podcast of 2024**
**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor. Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**
**May contain affiliate links and I will be compensated if you make a purchase after clicking on my links**
1,355 Listeners
69,185 Listeners
7,991 Listeners
262 Listeners
14,309 Listeners
1,003 Listeners
12,928 Listeners
28,567 Listeners
41,407 Listeners
2,056 Listeners
1,166 Listeners
19,518 Listeners
153 Listeners
8,203 Listeners
2 Listeners
0 Listeners
1,460 Listeners